Skip Navigation LinksHome > October 2006 - Volume 105 - Issue 4 > Mechanical Ventilation with Lower Tidal Volumes and Positive...
Anesthesiology:
Clinical Investigations

Mechanical Ventilation with Lower Tidal Volumes and Positive End-expiratory Pressure Prevents Alveolar Coagulation in Patients without Lung Injury

Choi, Goda M.D.*; Wolthuis, Esther K. M.D.†; Bresser, Paul M.D., Ph.D.‡; Levi, Marcel M.D., Ph.D.§; van der Poll, Tom M.D., Ph.D.∥; Dzoljic, Misa M.D., Ph.D.#; Vroom, Margreeth B. M.D., Ph.D.**; Schultz, Marcus J. M.D., Ph.D.††

Free Access
Article Outline
Collapse Box

Author Information

Collapse Box

Abstract

Background: Alveolar fibrin deposition is a hallmark of acute lung injury, resulting from activation of coagulation and inhibition of fibrinolysis. Previous studies have shown that mechanical ventilation with high tidal volumes may aggravate lung injury in patients with sepsis and acute lung injury. The authors sought to determine the effects of mechanical ventilation on the alveolar hemostatic balance in patients without preexistent lung injury.
Methods: Patients scheduled for an elective surgical procedure (lasting ≥ 5 h) were randomly assigned to mechanical ventilation with either higher tidal volumes of 12 ml/kg ideal body weight and no positive end-expiratory pressure (PEEP) or lower tidal volumes of 6 ml/kg and 10 cm H2O PEEP. After induction of anesthesia and 5 h later bronchoalveolar lavage fluid and blood samples were obtained, and markers of coagulation and fibrinolysis were measured.
Results: In contrast to mechanical ventilation with lower tidal volumes and PEEP (n = 21), the use of higher tidal volumes without PEEP (n = 19) caused activation of bronchoalveolar coagulation, as reflected by a marked increase in thrombin–antithrombin complexes, soluble tissue factor, and factor VIIa after 5 h of mechanical ventilation. Mechanical ventilation with higher tidal volumes without PEEP caused an increase in soluble thrombomodulin in lavage fluids and lower levels of bronchoalveolar activated protein C in comparison with lower tidal volumes and PEEP. Bronchoalveolar fibrinolytic activity did not change by either ventilation strategy.
Conclusions: Mechanical ventilation with higher tidal volumes and no PEEP promotes procoagulant changes, which are largely prevented by the use of lower tidal volumes and PEEP.
PULMONARY inflammation is characterized by local generation of proinflammatory mediators and a procoagulant shift of the alveolar hemostatic balance, promoting fibrin depositions within the airways.1,2 Disturbances in alveolar fibrin turnover have been demonstrated in patients with pneumonia3–6 and acute respiratory distress syndrome (ARDS).3,7 Whereas fibrin formation may aid in host protection, such as the containment of infectious agents during pulmonary infection and in maintaining or repairing the endothelial-epithelial barrier, on the other hand, coagulation products such as thrombin and fibrin have significant proinflammatory properties, potentially compromising pulmonary integrity and function.1,2 In its most extreme form, bronchoalveolar fibrin formation may compromise pulmonary function, as may occur with severe ARDS.
In severe lung injury, ventilatory support is almost invariably mandatory, but it is increasingly recognized that mechanical ventilation itself may aggravate or even initiate lung injurious processes.8,9 The so-called ventilator-associated lung injury is characterized by several pathophysiologic sequelae, including local generation of inflammatory mediators, constituting a pulmonary environment that is highly proinflammatory. Another hallmark of ventilator-associated lung injury in patients with severe lung injury is the activation of bronchoalveolar coagulation.5,6 In patients with ARDS, mechanical ventilation with lower tidal volumes improves patient survival,10 most likely by limiting generation of proinflammatory mediators, both locally in the lungs and systemically.11 It is unknown whether (mechanical ventilation–induced) alterations in the alveolar hemostatic balance contribute to outcome in mechanically ventilated patients. Moreover, there is ongoing debate on whether patients without preexistent lung injury would benefit from mechanical ventilation with lower tidal volumes, because large clinical trials have only investigated patients with acute lung injury and ARDS in the intensive care unit. Recently, the pulmonary and systemic inflammatory effects of mechanical ventilation were investigated in patients during major surgery, showing little alteration in the inflammatory responses.12,13
The aim of the current study was to characterize the effects of mechanical ventilation on the alveolar hemostatic balance. A randomized controlled trial was performed comparing two mechanical ventilation strategies in patients without preexistent lung injury who were scheduled to undergo a major surgical procedure.
Back to Top | Article Outline

Materials and Methods

Patients
The study protocol was approved by the Medical Ethics Committee of the University of Amsterdam (Amsterdam, The Netherlands), and informed consent was obtained from all patients. Adult patients were eligible if they were scheduled to undergo a surgical procedure of 5 h or more, and all involved physicians (surgeon, anesthesiologist, pulmonologist) consented with the study procedures, assuring safety of the patient. Exclusion criteria included a history of any lung disease, use of immunosuppressive medication, recent infections, previous thromboembolic disease, recent admission to the intensive care unit for ventilatory support, and participation in another clinical trial.
Back to Top | Article Outline
Study Protocol
All patients received routine anesthesia according to protocol, including intravenous propofol (2–3 mg/kg, thereafter 6–12 mg · kg−1 · h−1), fentanyl (2–3 μg/kg, thereafter as required), and rocuronium (as required); and epidural bupivacaine (0.125%)–fentanyl (2.5 μg/ml). The ventilatory protocol consisted of volume-controlled mechanical ventilation at an inspired oxygen fraction of 0.40, inspiratory to expiratory ratio of 1:2, and a respiratory rate adjusted to normocapnia. Randomization was performed by drawing a presealed envelope; patients were randomly assigned to mechanical ventilation with either tidal volumes of 12 ml/kg (ideal body weight, calculated according to the formula as described before)10 and no positive end-expiratory pressure (PEEP) or 6 ml/kg and 10 cm H2O PEEP. Anesthesiologists were allowed to change the ventilation protocol at any time point upon the surgeon's request, or if there was any concern about patient's safety. If the surgical procedure exceeded 5 h, anesthesiologists were allowed to change the ventilation strategy after the second sampling (blood and bronchoalveolar lavage). Patients were followed up until hospital discharge or death.
Bronchoscopy and bronchoalveolar lavage were performed twice on all patients: the first just after initiation of mechanical ventilation in either the right middle lobe or lingula, and the second performed in the contralateral lung 5 h thereafter, either perioperatively or directly postoperatively. Lavage fluid was obtained as previously described.4,6,14 In short, bronchoalveolar lavage was performed by an experienced pulmonologist in a standardized fashion according to the guidelines of the American Thoracic Society, using a flexible fiberoptic video-bronchoscope. Seven successive 20-ml aliquots of prewarmed normal saline were instilled and aspirated immediately with low suction (general recovery 10–15 ml). For coagulation assays, sodium citrate and benzamidin were added to the lavage fluids to a final concentration of 10 and 20 mm, respectively. Citrated (0.109 m) blood samples were drawn before both lavages, and hourly blood gas analyses were performed. Cell-free supernatants were stored at −80°C until analysis.
Back to Top | Article Outline
Assays for Coagulation and Fibrinolysis
Thrombin–antithrombin complex (TATc), soluble tissue factor, factor VIIa, tissue-type plasminogen activator (tPA), plasminogen activator inhibitor type 1 (PAI-1), plasminogen activator activity, soluble thrombomodulin, and activated protein C (APC) concentrations were measured as described before.15–17
Back to Top | Article Outline
Statistical Analysis
The required sample size was calculated from data from our previous investigations on pulmonary hemostasis.5,6 To detect differences in bronchoalveolar TATc concentrations in the study groups at a two-sided significance level of 5% with a power of 80%, the number of patients to be studied in each group was at least 19.
Baseline characteristics of the randomized patient groups were compared with the Student t test or Mann–Whitney U test, where appropriate. For categorical data, the chi-square test was used. Differences within groups were analyzed with a Wilcoxon signed-rank test for paired samples comparing t = 5 versus t = 0 h, and the Mann–Whitney U test was used to compare the changes over time between the two randomization groups. All results are expressed as mean ± SD. A P value of less than 0.05 was considered statistically significant. All statistical analyses were performed with SPSS 12.0 (SPSS, Chicago, IL).
Back to Top | Article Outline

Results

Patients
Fig. 1
Fig. 1
Image Tools
Table 1
Table 1
Image Tools
Seventy-four consecutive patients who were scheduled to undergo an elective surgical procedure of 5 h or more were screened in the period December 2003 through March 2005 (fig. 1). Twenty-eight patients were excluded, leaving 46 patients for randomization. Five patients were randomized but excluded from final analysis, because the initial surgical procedure was converted by the surgeon into another shorter operation (< 3 h), and only one bronchoalveolar lavage was performed. One patient was randomized, but no lavages were performed upon the surgeon's request after induction of anesthesia. In total, 40 patients completed the study protocol. There were no major differences between the two randomization groups with regard to baseline characteristics (table 1).
Table 2
Table 2
Image Tools
Fig. 2
Fig. 2
Image Tools
There were no adverse events related to the bronchoalveolar lavages. One surgeon reported hepatic congestion and requested PEEP levels to be reduced (patient ventilated with lower tidal volumes and PEEP). Aside from the mechanical ventilator settings (tidal volume, PEEP, and respiratory rate), there were no significant differences in perioperative hemodynamic parameters (table 2 and fig. 2). In particular, peak pressures were not different between the study groups during 5 h of mechanical ventilation.
Back to Top | Article Outline
Bronchoalveolar Coagulation and Fibrinolysis
Fig. 3
Fig. 3
Image Tools
Mechanical ventilation with higher tidal volumes and zero PEEP (HVT/ZEEP) caused activation of bronchoalveolar coagulation, as reflected in a marked increase in TATc, soluble tissue factor, and factor VIIa after 5 h of mechanical ventilation (all P < 0.001 vs. t = 0; fig. 3). In patients ventilated with lower tidal volumes and 10 cm H2O PEEP (LVT/PEEP), only soluble tissue factor was slightly increased (P < 0.01 vs. t = 0; fig. 3B) and far less pronounced than in patients with HVT/ZEEP (P < 0.001 between groups; fig. 3B).
Fig. 4
Fig. 4
Image Tools
Neither mechanical ventilation strategies were associated with changes in bronchoalveolar plasminogen activator activity (both within groups and between groups), despite a slight up-regulation of PAI-1 with HVT/ZEEP (P < 0.05 vs. t = 0; fig. 4). tPA was increased in both groups (both P < 0.001 vs. t = 0; fig. 4C), slightly more in HVT/ZEEP ventilation (P < 0.05 between groups).
Fig. 5
Fig. 5
Image Tools
There was a trend toward lower levels of bronchoalveolar APC with HVT/ZEEP as opposed to a trend toward higher APC with LVT/PEEP (fig. 5A). Between-group analysis did show a difference in changes of APC levels over time (P < 0.05 between groups). Mechanical ventilation with HVT/ZEEP caused an increase in soluble thrombomodulin as measured in lavage fluids (P < 0.05 vs. t = 0; fig. 5B), which was not with LVT/PEEP.
Back to Top | Article Outline
Systemic Hemostasis
During surgery, both systemic procoagulant and fibrinolytic activity were increased. In patients ventilated with HVT/ZEEP, there was an increase in TATc (6.1 ± 0.76 vs. 5.78 ± 1.10 ng/ml; P < 0.05) and plasminogen activator activity (103 ± 5.9 vs. 99 ± 6.5%; P < 0.01); in patients ventilated with LVT/PEEP, there was also an increase in TATc (5.63 ± 1.13 vs. 4.86 ± 1.09 ng/ml; P < 0.01), but only a trend toward higher plasminogen activator activity (102 ± 8.7 vs. 99 ± 6.6%). The changes over time were not different between the two mechanical ventilation strategies.
Back to Top | Article Outline
Postoperative Course
In the postoperative recovery, 28 patients had follow-up chest radiographs. There were no differences in postoperative arterial blood gas analyses (HVT/ZEEP vs. LVT/PEEP): partial pressure of oxygen 117 ± 42 versus 123 ± 53 mmHg, partial pressure of carbon dioxide 43 ± 5 versus 42 ± 5 mmHg, and pH 7.36 ± 0.053 versus 7.34 ± 0.051. There were no differences in incidence of pulmonary complications (e.g., acute lung injury, pneumonia) between the two study groups; in each study group, there was one patient requiring prolonged mechanical ventilation for respiratory failure after surgery. One patient ventilated with LVT/PEEP died postoperatively of multiple organ failure after complicated hemihepatectomy. All other patients were discharged home.
Back to Top | Article Outline

Discussion

Although mechanical ventilation with lower tidal volumes is generally considered to be protective in patients with acute lung injury, there is ongoing debate on the ideal tidal volumes in patients without preexistent lung injury. We here demonstrated that mechanical ventilation has significant effects on bronchoalveolar hemostasis: Although the duration of mechanical ventilation was only 5 h and no differences were observed in clinical parameters during the surgical procedure or in the recovery phase, local procoagulant activity was increased in the group of patients with noninjured lungs ventilated with 12 ml/kg and without the use of PEEP. Furthermore, we showed that mechanical ventilation with lower tidal volumes and PEEP can largely prevent these procoagulant changes. Simultaneously, there is up-regulation of plasminogen activation, which is not immediately reflected in increased fibrinolytic activity, perhaps—at least in patients ventilated with HVT/ZEEP—because of inhibitory effects of PAI-1. Finally, we demonstrated that mechanical ventilation with HVT/ZEEP causes generation of more soluble fragments of thrombomodulin in the bronchoalveolar spaces, potentially leading to an impaired activation of the protein C system. In summary, mechanical ventilation with HVT/ZEEP seems to promote fibrin depositions within the airways by three mechanisms: increased procoagulant activity via the extrinsic pathway, a relative insufficiency of the anticoagulant protein C system, and inhibition of fibrinolysis by PAI-1.
A “multiple-hit” model of lung injury can be theorized whereby predisposing conditions, such as injurious mechanical ventilation during surgery, may result in pulmonary inflammation (the “primary hit”). Then, several “second hits,” such as transfusion of blood products,18 prolonged (injurious) mechanical ventilation,11,19 aspiration,10,20 shock or sepsis,10,20 and ventilator-associated pneumonia,21 may all cause additional lung injury, finally resulting in full-blown ARDS with high morbidity and mortality. Although the current study was not designed to investigate clinical outcome, no differences were observed in the postoperative course between the study groups. However, the alterations in bronchoalveolar hemostasis may indicate that mechanical ventilation potentially has harmful effects, even in patients without acute lung injury.
The currently described changes in pulmonary hemostasis are similar as those previously described in patients with pneumonia or ARDS3–6 and in human volunteers with endotoxin-induced pulmonary inflammation.15,22 Consistently, increased procoagulant activity is reported, mostly related to the extrinsic coagulation pathway. It is likely that this activation is mediated by tissue factor expression on epithelial cells and mononuclear cells in the bronchoalveolar compartment. In the case of activation of epithelial and endothelial cells, by pathogens, excessive inflammation, or—as probably is the case during mechanical ventilation—mechanical strain, there will be disruption of the endothelial–epithelial barrier. Transudation of plasma into the bronchoalveolar compartment will subsequently initiate coagulation within the airways. We speculate that this is the mechanism leading to immediate “sealing” of the damaged area, providing injury containment, and initiating other repair systems. Also, PAI-1 up-regulation has been found consistently in patients with pneumonia,3–6 in patients with ARDS,3,7 and in our patients ventilated with HVT/ZEEP. Although in the current clinical settings this did not lead to a suppression of fibrinolytic activity, prolonged mechanical ventilation could lead to even higher levels of PAI-1 and more interference with fibrinolytic activity, as we demonstrated in patients developing ventilator-associated pneumonia.5,6 tPA antigens levels were increased by ventilation with both low and high tidal volumes. This is in contrast to in vitro studies by Dr. Günther's group, in which various cell lines all showed a down-regulation of tPA messenger RNA expression upon inflammatory stimuli.23 However, the same group reported in an in vivo model of endotoxin-induced lung injury that tPA is indeed up-regulated in both structural (alveolar type II cells, endothelial cells) and host defense cells (alveolar macrophages) in mouse lungs.24 Also in our recent report on endotoxin-induced lung inflammation in human volunteers, increased levels of tPA were observed.15 It is thought that this early activation of the fibrinolytic system is involved in tissue remodeling.25
We have shown before that in patients with pneumonia, protein C activation is suppressed, as well as after instillation of endotoxin in lungs of healthy volunteers.15,26 Mechanical ventilation with HVT/ZEEP induced shedding of soluble thrombomodulin into the airspaces, which is generally believed to represent epithelial or endothelial damage. On the other hand, there was a trend toward lower levels of APC, which was clearly opposite of the effect seen with LVT/PEEP ventilation. Recombinant human APC (rhAPC) has been shown to reduce mortality in patients with severe sepsis,27 in whom protective effects are believed to be beyond its anticoagulant properties. Despite vast data from in vitro and animal studies, however, it is still unclear how rhAPC acts in vivo. Systemic administration of rhAPC has significant effects in the lungs,15,28 suggesting that pulmonary effects of rhAPC may contribute to patient survival. Indeed, in the pivotal phase III study in patients with sepsis, the majority of patients had a pulmonary origin, and moreover, patients with pneumonia benefited mostly from rhAPC treatment.27,29,30
All of the described effects shift the hemostatic balance toward a procoagulant side, promoting fibrin depositions in the airways. The question remains whether this reflects an adaptive mechanism with host protective functions or whether it is a harmful process, predisposing the lungs to secondary complications or perhaps with long-term effects on pulmonary function. Fibrin deposition may be an important mechanism to repair endothelial or epithelial damage; however, an exaggerated coagulation activation has been related to a number of detrimental sequelae. Coagulation products have important proinflammatory effects,31 and in addition, ongoing fibrin depositions inactivate surfactant proteins, causing alveolar instability and collapse. Importantly, various anticoagulant strategies have been shown to limit lung injury in experimental studies,32 but potential beneficial effects must be confirmed in human patients.
To date, there have been few other reports on the effects of mechanical ventilation in patients with noninjured lungs. Gajic et al. 33,34 identified mechanical ventilation with higher tidal volumes as a risk factor for the development of acute lung injury in patients who did not have lung disease at the onset of mechanical ventilation. However, these patients were critically ill patients in an intensive care unit, developing ARDS after 48 h or more. Wrigge et al.12 recently showed that in patients undergoing major surgery with up to 3 h of mechanical ventilation, the ventilation strategy did not affect pulmonary or systemic cytokine levels, suggesting that a brief period of mechanical ventilation does not affect patients without systemic inflammation. Most recently, Wrigge et al.13 extended the duration of mechanical ventilation to 6 h by selecting patients undergoing cardiac surgery. Again, no systemic effects were observed, but postoperative levels of tumor necrosis factor α in bronchoalveolar lavage fluid were lower in patients ventilated with lower tidal volumes. However, measured cytokine levels were very low and highly variable. Therefore, we decided to lavage patients twice, immediately after initiation of mechanical ventilation and 5 h thereafter; this way, every patient would be his or her own control.
We here demonstrate for the first time that mechanical ventilation in patients with normal lungs induces a procoagulant shift in the alveolar hemostatic balance. Mechanical ventilation with lower tidal volumes and PEEP largely attenuates these changes in procoagulant activity within the airways. Clinical studies are warranted to establish the effects of prolonged mechanical ventilation (i.e., in an intensive care unit) on bronchoalveolar hemostasis, and the relation between alveolar procoagulant activity and patient outcome.
Back to Top | Article Outline

References

1. Levi M, Schultz MJ, Rijneveld AW, van der Poll T: Bronchoalveolar coagulation and fibrinolysis in endotoxemia and pneumonia. Crit Care Med 2003; 31:S238–42

2. Abraham E: Coagulation abnormalities in acute lung injury and sepsis. Am J Respir Cell Mol Biol 2000; 22:401–4

3. Günther A, Mosavi P, Heinemann S, Ruppert C, Muth H, Markart P, Grimminger F, Walmrath D, Temmesfeld-Wollbruck B, Seeger W: Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia: Comparison with the acute respiratory distress syndrome. Am J Respir Crit Care Med 2000; 161:454–62

4. Rijneveld AW, Florquin S, Bresser P, Levi M, De Waard V, Lijnen R, Van Der Zee JS, Speelman P, Carmeliet P, van der Poll T: Plasminogen activator inhibitor type-1 deficiency does not influence the outcome of murine pneumococcal pneumonia. Blood 2003; 102:934–9

5. Schultz MJ, Millo J, Levi M, Hack CE, Weverling GJ, Garrard CS, van der Poll T: Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator-associated pneumonia. Thorax 2004; 59:130–5

6. Choi G, Schultz MJ, van Till JW, Bresser P, Van Der Zee JS, Boermeester MA, Levi M, van der Poll T: Disturbed alveolar fibrin turnover during pneumonia is restricted to the site of infection. Eur Respir J 2004; 24:786–9

7. Idell S, Koenig KB, Fair DS, Martin TR, McLarty J, Maunder RJ: Serial abnormalities of fibrin turnover in evolving adult respiratory distress syndrome. Am J Physiol 1991; 261:L240–8

8. Slutsky AS: Lung injury caused by mechanical ventilation. Chest 1999; 116:9S–15S

9. Pinhu L, Whitehead T, Evans T, Griffiths M: Ventilator-associated lung injury. Lancet 2003; 361:332–40

10. The Acute Respiratory Distress Syndrome Network: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342:1301–8

11. Ranieri VM, Suter PM, Tortorella C, De Tullio, R, Dayer JM, Brienza A, Bruno F, Slutsky AS: Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: A randomized controlled trial. JAMA 1999; 282:54–61

12. Wrigge H, Uhlig U, Zinserling J, Behrends-Callsen E, Ottersbach G, Fischer M, Uhlig S, Putensen C: The effects of different ventilatory settings on pulmonary and systemic inflammatory responses during major surgery. Anesth Analg 2004; 98:775–81

13. Wrigge H, Uhlig U, Baumgarten G, Menzenbach J, Zinserling J, Ernst M, Dromann D, Welz A, Uhlig S, Putensen C: Mechanical ventilation strategies and inflammatory responses to cardiac surgery: A prospective randomized clinical trial. Intensive Care Med 2005; 31:1379–87

14. Maris NA, de Vos AF, Dessing MC, Spek CA, Lutter R, Jansen HM, Van Der Zee JS, Bresser P, van der PT: Antiinflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers. Am J Respir Crit Care Med 2005; 172:878–84

15. van der Poll T, Levi M, Nick JA, Abraham E: Activated protein C inhibits local coagulation after intrapulmonary delivery of endotoxin in humans. Am J Respir Crit Care Med 2005; 171:1125–8

16. Friederich PW, Levi M, Bauer KA, Vlasuk GP, Rote WE, Breederveld D, Keller T, Spataro M, Barzegar S, Buller HR: Ability of recombinant factor VIIa to generate thrombin during inhibition of tissue factor in human subjects. Circulation 2001; 103:2555–9

17. Liaw PC, Ferrell G, Esmon CT: A monoclonal antibody against activated protein C allows rapid detection of activated protein C in plasma and reveals a calcium ion dependent epitope involved in factor Va inactivation. J Thromb Haemost 2003; 1:662–70

18. Kopko PM, Marshall CS, MacKenzie MR, Holland PV, Popovsky MA: Transfusion-related acute lung injury: Report of a clinical look-back investigation. JAMA 2002; 287:1968–71

19. Ranieri VM, Giunta F, Suter PM, Slutsky AS: Mechanical ventilation as a mediator of multisystem organ failure in acute respiratory distress syndrome. JAMA 2000; 284:43–4

20. Spragg RG, Lewis JF, Walmrath HD, Johannigman J, Bellingan G, Laterre PF, Witte MC, Richards GA, Rippin G, Rathgeb F, Hafner D, Taut FJ, Seeger W: Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. N Engl J Med 2004; 351:884–92

21. Chastre J, Fagon JY: Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165:867–903

22. Maris NA, de Vos AF, Bresser P, Van Der Zee JS, Meijers JC, Lijnen HR, Levi M, Jansen HM, van der Poll T: Activation of coagulation and inhibition of fibrinolysis in the lung after inhalation of lipopolysaccharide by healthy volunteers. Thromb Haemost 2005; 93:1036–40

23. Muth H, Maus U, Wygrecka M, Lohmeyer J, Grimminger F, Seeger W, Günther A: Pro- and antifibrinolytic properties of human pulmonary microvascular versus artery endothelial cells: Impact of endotoxin and tumor necrosis factor-alpha. Crit Care Med 2004; 32:217–26

24. Wygrecka M, Markart P, Ruppert C, Kuchenbuch T, Fink L, Bohle RM, Grimminger F, Seeger W, Günther A: Compartment- and cell-specific expression of coagulation and fibrinolysis factors in the murine lung undergoing inhalational versus intravenous endotoxin application. Thromb Haemost 2004; 92:529–40

25. Idell S: Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit Care Med 2003; 31:S213–20

26. Choi G, Schultz MJ, Levi M, van der Poll T, Millo JL, Garrard CS: Protein C in pneumonia. Thorax 2005; 60:705–6

27. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699–709

28. Nick JA, Coldren CD, Geraci MW, Poch KR, Fouty BW, O'Brien J, Gruber M, Zarini S, Murphy RC, Kuhn K, Richter D, Kast KR, Abraham E: Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis. Blood 2004; 104:3878–85

29. Vincent JL, Angus DC, Artigas A, Kalil A, Basson BR, Jamal HH, Johnson G III, Bernard GR: Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial. Crit Care Med 2003; 31:834–40

30. Laterre PF, Garber G, Levy H, Wunderink R, Kinasewitz GT, Sollet JP, Maki DG, Bates B, Yan SC, Dhainaut JF: Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study. Crit Care Med 2005; 33:952–61

31. Levi M, van der Poll T, Büller HR: Bidirectional relation between inflammation and coagulation. Circulation 2004; 109:2698–704

32. Laterre PF, Wittebole X, Dhainaut JF: Anticoagulant therapy in acute lung injury. Crit Care Med 2003; 31:S329–36

33. Gajic O, Dara SI, Mendez JL, Adesanya AO, Festic E, Caples SM, Rana R, St Sauver JL, Lymp JF, Afessa B, Hubmayr RD: Ventilator-associated lung injury in patients without acute lung injury at the onset of mechanical ventilation. Crit Care Med 2004; 32:1817–24

34. Gajic O, Frutos-Vivar F, Esteban A, Hubmayr RD, Anzueto A: Ventilator settings as a risk factor for acute respiratory distress syndrome in mechanically ventilated patients. Intensive Care Med 2005; 31:922–6

Cited By:

This article has been cited 42 time(s).

Intensive Care Medicine
Prophylactic protective ventilation: lower tidal volumes for all critically ill patients?
Lellouche, F; Lipes, J
Intensive Care Medicine, 39(1): 6-15.
10.1007/s00134-012-2728-4
CrossRef
Plos One
Anti-Human Tissue Factor Antibody Ameliorated Intestinal Ischemia Reperfusion-Induced Acute Lung Injury in Human Tissue Factor Knock-In Mice
He, X; Han, B; Mura, M; Li, L; Cypel, M; Soderman, A; Picha, K; Yang, J; Liu, MY
Plos One, 3(1): -.
ARTN e1527
CrossRef
Thorax
Intraoperative ventilator settings and acute lung injury after elective surgery: a nested case control study
Fernandez-Perez, ER; Sprung, J; Afessa, B; Warner, DO; Vachon, CM; Schroedere, DR; Brown, DR; Hubmayr, RD; Gajic, O
Thorax, 64(2): 121-127.
10.1136/thx.2008.102228
CrossRef
Critical Care
Mechanical ventilation using non-injurious ventilation settings causes lung injury in the absence of pre-existing lung injury in healthy mice
Wolthuis, EK; Vlaar, APJ; Choi, G; Roelofs, JJTH; Juffermans, NP; Schultz, MJ
Critical Care, 13(1): -.
ARTN R1
CrossRef
Pediatric Anesthesia
Protective ventilation to reduce inflammatory injury from one lung ventilation in a piglet model
Theroux, MC; Fisher, AO; Horner, LM; Rodriguez, ME; Costarino, AT; Miller, TL; Shaffer, TH
Pediatric Anesthesia, 20(4): 356-364.
10.1111/j.1460-9592.2009.03195.x
CrossRef
British Journal of Pharmacology
Protective mechanisms of activated protein C in severe inflammatory disorders
Neyrinck, AP; Liu, KD; Howard, JP; Matthay, MA
British Journal of Pharmacology, 158(4): 1034-1047.
10.1111/j.1476-5381.2009.00251.x
CrossRef
Thorax
Pulmonary coagulopathy: a potential therapeutic target in different forms of lung injury
Schultz, MJ; Levi, M
Thorax, 62(7): 563-564.
10.1136/thx.2006.067256
CrossRef
Critical Care
Ventilation with lower tidal volumes as compared with conventional tidal volumes for patients without acute lung injury: a preventive randomized controlled trial
Determann, RM; Royakkers, A; Wolthuis, EK; Vlaar, AP; Choi, G; Paulus, F; Hofstra, JJ; de Graaff, MJ; Korevaar, JC; Schultz, MJ
Critical Care, 14(1): -.
ARTN R1
CrossRef
Critical Care
Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury
McClintock, D; Zhuo, HJ; Wickersham, N; Matthay, MA; Ware, LB
Critical Care, 12(2): -.
ARTN R41
CrossRef
British Journal of Anaesthesia
Comparison of two ventilatory strategies in elderly patients undergoing major abdominal surgery
Weingarten, TN; Whalen, FX; Warner, DO; Gajic, O; Schears, GJ; Snyder, MR; Schroeder, DR; Sprung, J
British Journal of Anaesthesia, 104(1): 16-22.
10.1093/bja/aep319
CrossRef
Medical Science Monitor
Lung-protective mechanical ventilation with lower tidal volumes in patients not suffering from acute lung injury: A review of clinical studies
Schultz, MJ
Medical Science Monitor, 14(2): RA22-RA26.

Frontiers in Bioscience
The role of platelets in acute lung injury (ALI)
Zarbock, A; Ley, K
Frontiers in Bioscience, 14(): 150-158.
10.2741/3236
CrossRef
Critical Care
Tissue factor as an initiator of coagulation and inflammation in the lung
van der Poll, T
Critical Care, 12(): -.
ARTN S3
CrossRef
American Journal of Physiology-Lung Cellular and Molecular Physiology
Procoagulant alveolar microparticles in the lungs of patients with acute respiratory distress syndrome
Bastarache, JA; Fremont, RD; Kropski, JA; Bossert, FR; Ware, LB
American Journal of Physiology-Lung Cellular and Molecular Physiology, 297(6): L1035-L1041.
10.1152/ajplung.00214.2009
CrossRef
Anesthesia and Analgesia
Low Tidal Volume and High Positive End-Expiratory Pressure Mechanical Ventilation Results in Increased Inflammation and Ventilator-Associated Lung Injury in Normal Lungs
Hong, CM; Xu, DZ; Lu, Q; Cheng, YHI; Pisarenko, V; Doucet, D; Brown, M; Aisner, S; Zhang, CX; Deitch, EA; Delphin, E
Anesthesia and Analgesia, 110(6): 1652-1660.
10.1213/ANE.0b013e3181cfc416
CrossRef
American Journal of Physiology-Lung Cellular and Molecular Physiology
Lung epithelial injury markers are not influenced by use of lower tidal volumes during elective surgery in patients without preexisting lung injury
Determann, RM; Wolthuis, EK; Choi, G; Bresser, P; Bernard, A; Lutter, R; Schultz, MJ
American Journal of Physiology-Lung Cellular and Molecular Physiology, 294(2): L344-L350.
10.1152/ajplung.00268.2007
CrossRef
Intensive Care Medicine
Mechanical ventilation aggravates transfusion-related acute lung injury induced by MHC-I class antibodies
Vlaar, APJ; Wolthuis, EK; Hofstra, JJ; Roelofs, JJTH; Boon, L; Schultz, MJ; Lutter, R; Juffermans, NP
Intensive Care Medicine, 36(5): 879-887.
10.1007/s00134-010-1802-z
CrossRef
Anesthesia and Analgesia
A Description of Intraoperative Ventilator Management and Ventilation Strategies in Hypoxic Patients
Blum, JM; Fetterman, DM; Park, PK; Morris, M; Rosenberg, AL
Anesthesia and Analgesia, 110(6): 1616-1622.
10.1213/ANE.0b013e3181da82e1
CrossRef
Anesthesia and Analgesia
Do new anesthesia ventilators deliver small tidal volumes accurately during volume-controlled ventilation?
Bachiller, PR; McDonough, JM; Feldman, JM
Anesthesia and Analgesia, 106(5): 1392-1400.
10.1213/ane.0b013e31816a68c6
CrossRef
Seminars in Thrombosis and Hemostasis
The Role of Bronchoalveolar Hemostasis in the Pathogenesis of Acute Lung Injury
Hofstra, JJH; Haitsma, JJ; Juffermans, NP; Levi, M; Schultz, MJ
Seminars in Thrombosis and Hemostasis, 34(5): 475-484.
10.1055/s-0028-1092878
CrossRef
European Respiratory Journal
Ventilator-induced coagulopathy in experimental Streptococcus pneumoniae pneumonia
Haitsma, JJ; Schultz, MJ; Hofstra, JJH; Kuiper, JW; Juco, J; Vaschetto, R; Levi, M; Zhang, H; Slutsky, AS
European Respiratory Journal, 32(6): 1599-1606.
10.1183/09031936.00045908
CrossRef
Gerontology
Preoperative maneuvers to avert postoperative respiratory failure in elderly patients
Gore, DC
Gerontology, 53(6): 438-444.
10.1159/000112001
CrossRef
Intensive Care Medicine
Do soluble mediators cause ventilator-induced lung injury and multi-organ failure?
Jaecklin, T; Otulakowski, G; Kavanagh, BP
Intensive Care Medicine, 36(5): 750-757.
10.1007/s00134-010-1850-4
CrossRef
Anesthesia and Analgesia
Pulmonary cytokine responses during mechanical ventilation of noninjured lungs with and without end-expiratory pressure
Meier, T; Lange, A; Papenberg, H; Ziemann, M; Fentrop, C; Uhlig, U; Schmucker, P; Uhlig, S; Stamme, C
Anesthesia and Analgesia, 107(4): 1265-1275.
10.1213/ane.0b013e3181806212
CrossRef
Thrombosis Research
The impact of the PAI-1 4G/5G polymorphism on the outcome of patients with ALI/ARDS
Tsangaris, I; Tsantes, A; Bonovas, S; Lignos, M; Kopterides, P; Gialeraki, A; Rapti, E; Orfanos, S; Dimopoulou, I; Travlou, A; Armaganidis, A
Thrombosis Research, 123(6): 832-836.
10.1016/j.thromres.2008.07.018
CrossRef
Translational Research
Role for nuclear factor-kappa B in augmented lung injury because of interaction between hyperoxia and high stretch ventilation
Liu, YY; Liao, SK; Huang, CC; Tsai, YH; Quinn, DA; Li, LF
Translational Research, 154(5): 228-240.
10.1016/j.trsl.2009.06.006
CrossRef
Transplantation Reviews
Intraoperative protective ventilation strategies in lung transplantation
Verbeek, GL; Myles, PS
Transplantation Reviews, 27(1): 30-35.
10.1016/j.trre.2012.11.004
CrossRef
Journal of Thrombosis and Haemostasis
Bronchoalveolar hemostasis in lung injury and acute respiratory distress syndrome
Glas, GJ; Van der Sluijs, KF; Schultz, MJ; Hofstra, JJH; Van der Poll, T; Levi, M
Journal of Thrombosis and Haemostasis, 11(1): 17-25.
10.1111/jth.12047
CrossRef
Anesthesiology
Mechanical Ventilation with Lower Tidal Volumes and Positive End-expiratory Pressure Prevents Pulmonary Inflammation in Patients without Preexisting Lung Injury
Wolthuis, EK; Choi, G; Dessing, MC; Bresser, P; Lutter, R; Schultz, MJ; Dzoljic, M; van der Poll, T; Vroom, MB; Hollmann, M
Anesthesiology, 108(1): 46-54.
10.1097/01.anes.0000296068.80921.10
PDF (965) | CrossRef
Anesthesiology
Perioperative Protective Ventilatory Strategies in Patients without Acute Lung Injuries
Schultz, MJ; Gajic, O
Anesthesiology, 108(2): 336-337.
10.1097/01.anes.0000300069.65154.12
PDF (402) | CrossRef
Anesthesiology
Association of High Tidal Volume with Postpneumonectomy Failure
Fernández Pérez, ER; Keegan, MT; Brown, DR; Hubmayr, RD; Gajic, O
Anesthesiology, 106(4): 876.
10.1097/01.anes.0000264783.69113.ff
PDF (910) | CrossRef
Anesthesiology
Lower Tidal Volumes and Positive End-expiratory Pressure Prevents Alveolar Coagulation in Patients without Lung Injury
Akça, O
Anesthesiology, 106(5): 1065-1066.
10.1097/01.anes.0000265178.21114.9d
PDF (542) | CrossRef
Anesthesiology
What Tidal Volumes Should Be Used in Patients without Acute Lung Injury?
Schultz, MJ; Haitsma, JJ; Slutsky, AS; Gajic, O
Anesthesiology, 106(6): 1226-1231.
10.1097/01.anes.0000267607.25011.e8
PDF (270) | CrossRef
Anesthesiology
Lung Injury and Recovery in a Murine Model of Unilateral Acid Aspiration: Functional, Biochemical, and Morphologic Characterization
Amigoni, M; Bellani, G; Scanziani, M; Masson, S; Bertoli, E; Radaelli, E; Patroniti, N; Di Lelio, A; Pesenti, A; Latini, R
Anesthesiology, 108(6): 1037-1046.
10.1097/ALN.0b013e318173f64f
PDF (1657) | CrossRef
Anesthesiology
Protective Ventilation during One-lung Ventilation
Michelet, P
Anesthesiology, 107(1): 177.
10.1097/01.anes.0000268572.14940.73
PDF (68) | CrossRef
Critical Care Medicine
Recombinant human activated protein C inhibits local and systemic activation of coagulation without influencing inflammation during Pseudomonas aeruginosa pneumonia in rats
Choi, G; Hofstra, JH; Roelofs, JJ; Florquin, S; Bresser, P; Levi, M; van der Poll, T; Schultz, MJ
Critical Care Medicine, 35(5): 1362-1368.
10.1097/01.CCM.0000261888.32654.6D
PDF (769) | CrossRef
Current Opinion in Anesthesiology
Update on one-lung ventilation: the use of continuous positive airway pressure ventilation and positive end-expiratory pressure ventilation – clinical application
Grichnik, KP; Shaw, A
Current Opinion in Anesthesiology, 22(1): 23-30.
10.1097/ACO.0b013e32831d7b41
PDF (171) | CrossRef
Current Opinion in Anesthesiology
Acute lung injury and outcomes after thoracic surgery
Licker, M; Fauconnet, P; Villiger, Y; Tschopp, J
Current Opinion in Anesthesiology, 22(1): 61-67.
10.1097/ACO.0b013e32831b466c
PDF (123) | CrossRef
Current Opinion in Critical Care
Extracellular matrix and mechanical ventilation in healthy lungs: back to baro/volotrauma?
Pelosi, P; Negrini, D
Current Opinion in Critical Care, 14(1): 16-21.
10.1097/MCC.0b013e3282f25162
PDF (116) | CrossRef
European Journal of Anaesthesiology (EJA)
Ventilatory management during routine general anaesthesia
Hans, GA; Sottiaux, TM; Lamy, ML; Joris, JL
European Journal of Anaesthesiology (EJA), 26(1): 1-8.
10.1097/EJA.0b000e000000f1fb
PDF (164) | CrossRef
Shock
Recombinant Human Soluble Tumor Necrosis Factor-Alpha Receptor Fusion Protein Partly Attenuates Ventilator-Induced Lung Injury
Wolthuis, EK; Vlaar, AP; Choi, G; Roelofs, JJ; Haitsma, JJ; van der Poll, T; Juffermans, NP; Zweers, MM; Schultz, MJ
Shock, 31(3): 262-266.
10.1097/SHK.0b013e31817d42dd
PDF (1423) | CrossRef
Shock
Pulmonary Levels of High-Mobility Group Box 1 During Mechanical Ventilation and Ventilator-Associated Pneumonia
van Zoelen, MA; Ishizaka, A; Wolthuis, EK; Choi, G; van der Poll, T; Schultz, MJ
Shock, 29(4): 441-445.
10.1097/SHK.0b013e318157eddd
PDF (168) | CrossRef
Back to Top | Article Outline

© 2006 American Society of Anesthesiologists, Inc.

Publication of an advertisement in Anesthesiology Online does not constitute endorsement by the American Society of Anesthesiologists, Inc. or Lippincott Williams & Wilkins, Inc. of the product or service being advertised.
Login

Article Tools

Images

Share